Special characteristics and potential for radiopharmaceuticals for positron emission tomography
AP Wolf - Seminars in Nuclear Medicine, 1981 - Elsevier
The development of accelerator-produced radionuclides is undergoing a rapid if not
exponential increase worldwide. The single photon emitters gallium-67, thallium-201 (iodine …
exponential increase worldwide. The single photon emitters gallium-67, thallium-201 (iodine …
Positron emission tomography: radioisotope and radiopharmaceutical production.
HJ Tochon-Danguy, JI Sachinidis, GF Egan… - … Sciences in Medicine, 1999 - europepmc.org
A Centre for Positron Emission Tomography (PET) has been operational within the
Department of Nuclear Medicine at the Austin & Repatriation Medical Centre (A&RMC) in …
Department of Nuclear Medicine at the Austin & Repatriation Medical Centre (A&RMC) in …
[图书][B] Radiopharmaceuticals for Positron Emission Tomography-Methodological Aspects
G Stöcklin, VW Pike - 1993 - books.google.com
Radiochemical methodology constitutes the most important base for the successful
functioning of a PET group in the routine production and development of …
functioning of a PET group in the routine production and development of …
Radiopharmaceutical chemistry for positron emission tomography
Z Li, PS Conti - Advanced drug delivery reviews, 2010 - Elsevier
Molecular imaging is an emerging technology that allows the visualization of interactions
between molecular probes and biological targets. Molecules that either direct or are subject …
between molecular probes and biological targets. Molecules that either direct or are subject …
New directions in positron emission tomography
JS Fowler, AP Wolf - Annual Reports in Medicinal Chemistry, 1989 - Elsevier
Publisher Summary This chapter describes the design and synthesis of radiotracers labeled
with the short lived cyclotron produced nuclides and the application of positron emission …
with the short lived cyclotron produced nuclides and the application of positron emission …
Principles and clinical applications of positron emission tomography
SF Gardner, JA Green, EM Bednarczyk… - American journal of …, 1992 - academic.oup.com
The basics of positron emission tomography (PET) are presented, including the physics,
instrumentation, and radiopharmaceuticals involved; the clinical and research applications; …
instrumentation, and radiopharmaceuticals involved; the clinical and research applications; …
Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging
GB Saha, WJ MacIntyre, RT Go - Seminars in nuclear medicine, 1992 - Elsevier
Positron emission tomography (PET) requires positronemitting radionuclides that emit 511-
keV photons detectable by PET imagers. Positron-emitting radionuclides are commonly …
keV photons detectable by PET imagers. Positron-emitting radionuclides are commonly …
Positron emission tomography instrumentation
FH Fahey - Radiologic Clinics of North America, 2001 - Elsevier
Positron emission tomography (PET) is a method by which the in vivo distribution of a
radiopharmaceutical can be measured with high resolution and sensitivity. Conventional …
radiopharmaceutical can be measured with high resolution and sensitivity. Conventional …
Positron emitter-labeled radiotracers-Chemical considerations
AP Wolf, JS Fowler - Positron emission tomography, 1985 - inis.iaea.org
[en] Positron emission tomography (PET) is a relatively new scientific tool that has allowed
scientists and physicians to address problems in physiology and biochemistry in the living …
scientists and physicians to address problems in physiology and biochemistry in the living …
A brief history of positron emission tomography (PET)
HN Wagner Jr - Seminars in nuclear medicine, 1998 - Elsevier
The development of positron emission tomography (PET) illustrates how advances in basic
science translates into benefits for human beings. In 1930 Ernest Lawrence and co-workers …
science translates into benefits for human beings. In 1930 Ernest Lawrence and co-workers …